Caitlin Raymond: Augmented Intelligence Enhancing Human Capability Without Replacement
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at University of Wisconsin-Madison, shared a post on LinkedIn:
“The AI in medicine discourse has two settings: it’s going to replace physicians, or it’s too dangerous to touch.
Both arguments imagine AI as an autonomous agent.
That’s not how I use it, and I don’t think it’s how physicians should.
There’s a better frame: augmented intelligence.
- The AI amplifies your thinking, drafting, and analysis
- You retain intellectual ownership of the output
- You direct the work, evaluate what comes back, and correct what’s wrong
- Accountability never leaves the physician
In practice, I use Claude for writing and coding – drafting posts, structuring arguments, generating diagrams.
I use Gemini for assistant tasks.
In every case, I’m directing the work and evaluating the output critically before anything goes anywhere.
The post that goes up is mine.
The thinking is mine.
The AI accelerated production of a written artifact that represents my analysis.
It did not perform the analysis.
Anyone in laboratory medicine already understands the oversight principle intuitively.
We don’t report analyzer results without understanding what the analyzer did.
We run QC.
We investigate flags.
AI output requires the same scrutiny — because the distinctive failure mode of these tools isn’t garbled output. It’s fluent, confident, plausible-sounding output that is wrong.
And on opting out: physicians who wait aren’t avoiding risk.
They’re outsourcing the learning curve.
Someone will set the norms for how AI gets used in your institution and your specialty.
Better that it’s clinicians with hands-on experience than administrators and vendors who don’t see patients.
Augmented intelligence, done right, is not about ceding judgment to a machine.
It’s about using a powerful tool with the same rigor we bring to every other tool in medicine.
Full post in the first comment.”

Other posts featuring Caitlin Raymond on Hemostasis Today.
-
Jul 14, 2026, 19:35Daratumumab in Difficult-to-Treat iTTP: Updated Results from the International DarTTP Study
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026